Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Immuron Ltd IMRN

Healthcare Biotechnology
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal... see more

Current News (NDAQ:IMRN)

Immuron New U.S. Department of Defense Award & Clinical Trial Update

GlobeNewswire December 3, 2025

Immuron IMM-529 IND approved by FDA

GlobeNewswire November 5, 2025

Immuron Announces Clinical Trial Update

GlobeNewswire October 31, 2025

Immuron Q1 FY26 YoY growth

GlobeNewswire October 13, 2025

Immuron Submits IMM-529 IND to FDA

GlobeNewswire October 8, 2025

Immuron Letter to Shareholders - Projects Update

GlobeNewswire October 2, 2025

Immuron partners with InvestorHub

GlobeNewswire August 26, 2025

Immuron - FY25 global sales exceed projection, up 49% on prior year

GlobeNewswire July 17, 2025

Immuron Letter to Shareholders: Projects Update

GlobeNewswire May 30, 2025
View More News ››

Opinion & Analysis (NDAQ:IMRN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:IMRN)

Immuron Live Streaming!

Looks like IMMuron about to present at this conference, https://2ly.link/1yXNe , check it out!
Johnthe6 - June 20, 2024

immuron new virtual event

I saw that Immuron is going to present at this free virtual conference! Register link-->  https://buff.ly/4bSLhjm
Johnthe6 - June 17, 2024

Immuron's virtual conference

They said Immuron is going to give a talk at this virtual event, And i found that the register is free! https://buff.ly/4bSLhjm 
Johnthe6 - June 5, 2024

IMRN...... Vols are increasing and getting Price action

Small float......could gap up   JMHO
Iseneschal - December 23, 2022

IMRN.... FDA approval for IND

On watch
Iseneschal - December 23, 2022

it's a buy today for me

got in this morning,so glta shareholders.
coolfooldumbguy - October 2, 2019
View more Bullboard ››

Mullen Group Ltd

Mullen Group Ltd

Mullen Group Ltd. provides a range of trucking and logistics services in Canada and the United States. It operates through ...
View More »

Podcasts